Class II · Moderate riskOngoing Initiated Jul 10, 2025 (14 months ago)
Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviations; particulates identified during visual inspection
What was recalled
Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001, Made in Austria, Carton NDC- 60793-702-10 , Syringe NDC-60793-702-04
Recalling firm
Pfizer Inc.
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0545-2025
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Labeling: Label Mix-Up; Some vials of Cefazolin for Injection, USP 1 gram were incorrectly labeled as penicillin G potassium for Injection, USP, 20…